Spectral evidence for defect clustering: Relevance to radiation dosimetry materials

The accumulation of experimental evidence available in the literature, especially from optical emission and excitation spectra, demonstrates that defect sites in luminescent materials are primarily complexes extending over multiple lattice sites. Included in such luminescent materials are those used in luminescence dosimetry (using thermoluminescence and/or optically stimulated luminescence). When defect complexes form, an understanding of recombination processes in these materials must include charge transfer via both delocalized and localized mechanisms, including both excited state and ground state tunnelling among nearest-neighbour sites. The various clustering mechanisms and recombination pathways that result from defect cluster formation are complex and described by a multitude of relevant parameters. There is no obvious route to optimising so many parameters, except by trial and error through massive amounts of experimentation, as everything from composition, growth, powder formation and subsequent thermal treatments can make dramatic changes to final luminescence and dosimetric properties. Reliance on idealised historic models is inappropriate in terms of improving practical dosimeters.

Automated summary

Experimental evidence shows that defect sites in luminescent materials are complexes extending over multiple lattice sites. Recombination processes in these materials involve charge transfer via both delocalized and localized mechanisms, influenced by various clustering mechanisms and recombination pathways resulting from defect cluster formation. There is no obvious route to optimizing parameters, requiring trial and error through massive experimentation.